Edgewise Therapeutics Inc. Common Stock vs Seaboard Corporation Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Seaboard Corporation Common Stock trades at $4,019 (market cap $3.80B). The key difference: Edgewise Therapeutics Inc. Common Stock and Seaboard Corporation Common Stock are close in size by market cap, and Seaboard Corporation Common Stock pays a 0.23% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Seaboard Corporation Common Stock for 0 Days on average.
| EWTX | SEB | |
|---|---|---|
Market Cap | $3.94B | $3.80B |
Volume | 810,104 | 9,086 |
Sector | Health | Industrials |
52-Week High | $48.35 | $5.96K |
52-Week Low | $14.89 | $3.22K |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $4.57B |
Dividend Yield | — | 0.23% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Seaboard Corporation is a diversified agribusiness and transportation company operating through pork production, commodity trading and milling, marine cargo shipping, liquid fuels, power generation, and turkey production segments, including its Seaboard Foods and Butterball businesses. It operates across North America, the Caribbean, South America, Africa, and Europe.
Read more on SEB →